top of page
Search
  • Writer's pictureFutureMeds

FutureMeds partners with Medeusz-Plus to open Dedicated Research Site in Olsztyn

Updated: Jan 24, 2023

FutureMeds expands its network and partners with Medeusz-Plus, a renowned cardiovascular clinic in Olsztyn, northern Poland, helping clients & patients get access to medical solutions they need and deserve.


FutureMeds’ team believes the partnership with Medeusz-Plus will provide another powerful research site for clients and will support clinical trials in finding new treatments in the region without costly delays.


Medeusz-Plus is a specialist medical centre and clinical trials site operating in Olsztyn since 2011. Among other treatment areas, the clinic offers state-of-the-art treatment in the field of internal medicine, cardiology, endocrinology and rheumatology.


“It is a great opportunity for all patients in our region to benefit from clinical trials which will come with FutureMeds.” commented Dr Maciej Zechowicz, owner and Principal Investigator of Medeusz-Plus. “Our combined expertise and dedication will significantly improve delivery of clinical trials in Olsztyn and in the whole region. We will be extending our clinical expertise offering even more therapy area coverage in the near future.”


As a Decentralised Trial Center of Excellence, the Olsztyn site will collaborate with Medeusz-Plus’ experienced team to recruit & retain patients, execute clinical studies and provide expertise in local legislation & engagement with Ethics Committees and Institutional Review Boards.


Leveraging FutureMeds’ Dedicated Research Site Network Model, the Olsztyn team will support FutureMeds on its mission to streamline the clinical trial process for Clinical Research Organisations & pharmaceuticals and decrease clinical trial delays that can cost £6m+ every day in lost net present value.


One of the major contributors to delays and costs is patient recruitment and retention within the trials. FutureMeds Model of a network of Dedicated Research Sites drives 3 times more patients per site than the fragmented models, gives access to high-performing trial centres, enhances patient experience, and enables clients to access a wider & more diverse patient community.



About FutureMeds


FutureMeds is a fast-growing independent Dedicated Research Site Network supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them.


FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate patient access to new treatments.


Through acquisitions and a strategic focus on patient experience, FutureMeds has developed qualified patient pools across Europe that enables faster patient enrollment and strong retention and help generate more accurate results.


Follow us on LinkedIn


Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.


bottom of page